PATH Stock Analysis — UiPath
Sector: Software
AI Verdict
PATH trades at 13.5x next year's earnings while analysts expect nearly 50% EPS growth — that's cheap for the growth you're getting, and the moat looks credible if enterprise automation adoption continues.
Competitive Moat
UiPath builds robotic process automation (RPA) software that integrates deeply into enterprise workflows, making it costly and disruptive for customers to switch providers. Its defensibility comes from a combination of proprietary automation tools, sticky enterprise deployments, and a large library of pre-built automation components.
Summary
UiPath is notable for its RPA platform, which automates repetitive business tasks and is seeing rapid expected earnings growth.
Where It Stands
PATH returned 12.7% revenue growth last year and trades at 13.5x forward earnings, well below the software sector median of 35x, with analysts expecting 48.2% EPS growth.
Key Metrics
- Trailing P/E: 20.0x
- Forward P/E: 13.5x
- PEG Ratio: 0.42
- Earnings Growth: +0.5%
- Revenue Growth: +0.1%
- 52-Week High: $19.84
- 52-Week Low: $9.28
Analyst Consensus
10 Buy · 17 Hold · 1 Sell (28 analysts)
Bull Case
With a forward P/E of 13.5x and 48.2% expected EPS growth, the stock is cheap for the growth on offer if UiPath's automation platform keeps winning sticky enterprise deals.
Bear Case
If PATH's P/E reverts up to the 35x sector median without delivering on 48.2% EPS growth, buyers could face a sharp correction if growth disappoints.
Catalyst to Watch
Watch for major enterprise contract wins or renewals, as these will confirm whether UiPath's platform remains mission-critical and sticky.